Table 3.
Correlation of calprotectin and other variables in PCOS group.
Age | r | 0.044 |
P | .697 | |
BMI | r | 0.273 |
P | .192 | |
WC | r | 0.212 |
P | .045 | |
HC | r | 0.206 |
P | .041 | |
WHR | r | 0.072 |
P | .570 | |
Neutrophil | r | 0.048 |
P | .708 | |
Estradiol | r | 0.075 |
P | .515 | |
DHEA-S | r | 0.139 |
P | .262 | |
Glukose | r | 0.054 |
P | .616 | |
CRP | r | 0.422 |
P | .151 | |
NLR | r | 0.060 |
P | .638 | |
TT | r | 0.245 |
P | .021 | |
HOMA-IR | r | 0.295 |
P | .005 |
Statistical significance was defined as P < .05.
BMI = body mass index, CRP = serum C-reactive protein, DHEA-S = dehydroepiandrosterone sulfate, HC = hip circumference, HOMA-IR = Homeostatic Model Assessment for Insulin Resistance, NLR = neutrophil-lymphocyte ratio, PCOS = polycystic ovary syndrome, r = correlation coefficient, TT = total testosterone, WC = waist circumference, WHR = waist-to-hip ratio.